Cargando…
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
INTRODUCTION: Triple artemisinin-based combination therapies (TACTs) are being developed as a response to artemisinin and partner drug resistance in the treatment of falciparum malaria in Southeast Asia. In African countries, where current artemisinin-based combination therapies (ACTs) are still eff...
Autores principales: | de Haan, Freek, Bolarinwa, Oladimeji Akeem, Guissou, Rosemonde, Tou, Fatoumata, Tindana, Paulina, Boon, Wouter P. C., Moors, Ellen H. M., Cheah, Phaik Yeong, Dhorda, Mehul, Dondorp, Arjen M., Ouedraogo, Jean Bosco, Mokuolu, Olugbenga A., Amaratunga, Chanaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407563/ https://www.ncbi.nlm.nih.gov/pubmed/34464398 http://dx.doi.org/10.1371/journal.pone.0256567 |
Ejemplares similares
-
Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
por: Tindana, Paulina, et al.
Publicado: (2022) -
Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
por: Tindana, Paulina, et al.
Publicado: (2021) -
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023) -
A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria
por: Mokuolu, Olugbenga Ayodeji, et al.
Publicado: (2023) -
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021)